Literature DB >> 8739465

Cervical mucus anti-sperm antibodies: treatment with intrauterine insemination.

W H Kutteh1, W Byrd, L Blankenship, C C Kutteh, B R Carr.   

Abstract

PROBLEM: To determine (1) the incidence of cervical mucus anti-sperm antibodies in infertile women, and (2) the results of treatment by intrauterine insemination.
METHOD: Cervical mucus was collected the morning after urinary LH surge occurred from 153 consecutive women being treated for unexplained infertility with intrauterine insemination. Immunobead testing for IgG, IgA, IgA1, and IgA2 was performed with only actively motile sperm being counted.
RESULTS: Overall, 23/153 (15.0%) of cervical mucus samples were positive for anti-sperm antibodies: 9/23 (39.1%) were only IgA-positive (62% IgA1-positive, 38% IgA2-positive), 11/23 (47.8%) were only IgG-positive, and 3/23 (13.0%) were positive for both IgA and IgG. Insemination resulted in a pregnancy in 6/23 (26.1%) of women with cervical mucus anti-sperm antibodies after 1-3 cycles.
CONCLUSIONS: Testing for cervical mucus anti-sperm antibodies should be performed in cases of "unexplained" infertility, and intrauterine insemination may be an effective treatment, resulting in pregnancies in over one-fourth of couples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739465     DOI: 10.1111/j.1600-0897.1996.tb00505.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  1 in total

1.  A novel protein biochip screening serum anti-sperm antibody expression and natural pregnancy rate in a follow-up study in Chinese infertility.

Authors:  Feihong Xu; Lei Ye; Yuan Hu; Chengyun Cai; Zhen Wang; Liqing Fan; Lihua Song; Zhenshan Xu; Weidong Du
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.